Whalegun
Home

GMS Ventures & Investments reported a 50.3% stake in Outlook Therapeutics OTLK · 29,040,929 sh · amendment

Trade details

Type
5% stake report
Report
13D · amendment
Stake
50.3%
Last report
41.6% · filed 25/03/12
Shares held
29,040,929 sh
Class
Common Stock, par value $0.01 per share
Stock
Outlook Therapeutics OTLK
Holder
GMS Ventures & Investments
Event date
25/05/27
Filed
25/05/28

50.3% stake · +8.7pp from the last report

Stake
50.3%
Last report
41.6%
Since last report
+8.7pp

Outlook Therapeutics trades, last 26 weeks

What else happened in Outlook Therapeutics around then

Filed or reported within 30 days of the trade day · 25/04/27~25/06/26

GMS Ventures & Investments's other 5% stake reports